In at-risk medical patients, rivaroxaban after discharge did not reduce symptomatic or fatal VTE at 45 days
- PMID: 30557417
- DOI: 10.7326/ACPJC-2018-169-12-064
In at-risk medical patients, rivaroxaban after discharge did not reduce symptomatic or fatal VTE at 45 days
Comment on
-
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30145946 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources